Lexeo Therapeutics Earnings
NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.23+0.02 (+0.62%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.33
Lexeo Therapeutics earnings summary
Lexeo Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.33.
Summary generated from market data by MetaCap's automated system. Methodology